πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 262 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9827215

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820952

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822057

Solid forms of treprostinil

United Therapeutics Corporation Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775820

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9757377

Solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9744132

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701636

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compos

Akebia Therapeutics, Inc. Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682988

Solid salt form of Ξ±-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof

Nektar Therapeutics Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675588

Ondansetron extended release solid dosage forms for treating either nausea, vomiting or di

RedHill Biopharma Ltd. Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9670163

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636305

Antiemetic extended release solid dosage forms

RedHill Biopharma Ltd. Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9606124

Methods of detecting and treating stem-cell containing solid tumors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492538

Isolation and use of solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486411

Solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486446

Orally disintegrating solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9434717

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-me

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394358

Gene signature for predicting prognosis of patients with solid tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9364438

Process for producing solid particles

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9314455

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-me

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9308213

Solid solution compositions and use in chronic inflammation

Infirst Healthcare Limited Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9265730

Stable solid preparations

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9255063

Colchicine solid-state forms; methods of making; and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9241910

Orally-disintegrating solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9173849

Solid pharmaceutical composition

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted